DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy

scientific article published on 17 January 2017

DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BMCL.2017.01.050
P698PubMed publication ID28131710

P2093author name stringYan Li
Li Luo
Rui Xu
Xia Yang
Yong Deng
Xiaoming Qiang
Yunxiaozhu Zheng
Zhenghuai Tan
Zhongcheng Cao
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectAlzheimer's diseaseQ11081
edaravoneQ335099
P1104number of pages5
P304page(s)718-722
P577publication date2017-01-17
P1433published inBioorganic & Medicinal Chemistry LettersQ2709483
P1476titleDL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy
P478volume27

Reverse relations

Q55456183Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease.cites workP2860

Search more.